SI
MDT icon

Sava Infond’s Medtronic MDT Stock Holding History

Sava Infond’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$653K Sell
8,350
-2,330
-22% -$188K 0.05% 131
2026
Q1 		$925K Sell
10,680
-580
-5% -$55.6K 0.13% 107
2025
Q4 		$1.08M Buy
11,260
+1,060
+10% +$103K 0.15% 92
2025
Q3 		$971K Sell
10,200
-2,300
-18% -$211K 0.14% 99
2025
Q2 		$1.09M Hold
12,500
– – 0.17% 87
2025
Q1 		$1.12M Hold
12,500
– – 0.21% 86
2024
Q4 		$999K Buy
+12,500
New +$1.08M 0.18% 87

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Sava Infond's MDT Position: Q2 2026 in Review

Sava Infond reduced its Medtronic (MDT) stake by 22% in Q2 2026, selling an estimated $188K and leaving 8,350 shares worth $653K. The position accounts for 0.05% of the portfolio, ranked #131.

Sava Infond first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.12M in Q1 2025. 493 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Sava Infond held 8,350 shares of Medtronic worth $653K as of Q2 2026.
  • Sava Infond sold 2,330 Medtronic shares in Q2 2026, an estimated $188K.
  • Medtronic made up 0.05% of Sava Infond's portfolio in Q2 2026, its #131 holding.
  • Sava Infond first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Medtronic position peaked at $1.12M in Q1 2025.
  • 493 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.